2-Part Research Paper for BUSI 2702:
(Part 1 of 2): Why Valeant Pharmaceuticals should buy into India’s booming R&D market
Domestic pharmaceuticals in India have struggled with competing with larger pharmaceuticals who have a greater ability to lower prices. Valeant Pharmaceuticals will be able to exploit this market weakness as a large Big Pharma firm themselves, using their global reach and extensive manufacturing abilities. (excerpt)
(Part 2 of 2): Overcoming international management challenges in India for Valeant Pharmaceuticals
[A+ Paper from Fall 2013, BUSI 2702] The landscape of Indian business carries its own share of challenges, both socio-economic, and political. Valeant’s managers must be able to adapt and learn the cultural values of the Indian workplace to succeed in a competitive market and to bring growth to Valeant’s international portfolio of drug brands. (excerpt)
Business Marketing Case Study (Volkswagen) Group Project. Click here to view slides. (c) 2014.